Stay updated with breaking news from Executive Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer forecast more than $50 billion in 2022 sales for its COVID-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.
Ojai's Community Newspaper since 1891, makers of Ojai Valley Guide magazine, local News, Ojai Real Estate Weekly, Events, Arts, Sports, Opinion and more.
Pfizer Inc's experimental antiviral pill to treat Covid-19 was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing
Pfizer Inc's experimental antiviral pill to treat Covid-19 was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing
POLITICO Get the POLITICO Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. 05/12/2021 10:00 AM EDT Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need with ...